InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: Valuator2 post# 168441

Monday, 01/09/2023 2:35:03 PM

Monday, January 09, 2023 2:35:03 PM

Post# of 198709
Yeah it's a little tangly.

- It would seem all profit would flow up to the parent entity (unnamed European pharma company), and Enzolytics says the deal gives Enzolytics 50% of "profit derived from sales in the Licensed Territory" without specifying ITV-1 profits only. They left it ambiguous.

- How could Enzolytics have 50% ownership across the board but not 50% revenue sharing across the board?

- If the revenue sharing part of the deal was indeed for ITV-1 revenue only, there would be no revenue since ITV-1 isn't for sale yet.



If instead ENZC would share all profits from this entity, here are some possibilities:

- ENZC should already have been showing revenue and its accounting is bad.

- That parent entity is making zero revenue and thus has none to share.

- That part of the agreement hasn't taken effect yet. ( "Enzolytics will receive $1 Million USD and 50% ownership in the Licensing Entity valued at $8 Million.")



Will be curious to see how it transpires.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News